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Letter to the editor
Sex differences in adherence to guidelines
in aspirin prescription in a population
of low-risk cardiovascular patients
Anna Vittoria Mattioli, Antonio Manenti and Alberto Farinetti
Dear Editor,
We have read with great interest the paper Age and
gender differences in medical adherence after myocardial
infarction: Women do not receive optimal treatment -
The Netherlands claims database by Eindhoven and
coworkers1 and we found it of importance with a
view to clinical prevention. The authors assess medical
adherence during 1 year following myocardial infarc-
tion, stratifying per type of infarct, age and sex. They
concluded that age and sex differences existed in med-
ical adherence after myocardial infarction. Medical
adherence was lower in women, young patients and
elderly patients, specifically in non-ST-elevation myo-
cardial infarction (NSTEMI) patients.
With reference to the findings reported in the paper,
we would like to make the following contribution to the
discussion. Aspirin is widely used in low risk patients
with cardiovascular disease to prevent thrombosis, des-
pite the increasing risk of bleeding. We evaluated the
adherence to guidelines in aspirin prescription in 2095
patients (960 men (45.8%) and 1135 women (54.2%),
mean age 58 12 years) affected by minor rectal hem-
orrhage. The daily aspirin dosage ranged from 80 to
500mg. We found that 220 patients were treated with
aspirin (10.9%), specifically they were 120 men (12.5%)
and 100 women (9.4%), (p< 0.05). Of these 220, 205
(75.1%) were treated with aspirin according to the
guidelines for prevention of cardiovascular disease;
10 patients were treated with aspirin out of guideline
indications. In addition, 683 patients (32.6%) that
needed aspirin or anti-platelet therapy due to their car-
diovascular risk were not treated, despite not having
contraindications or allergy. Adherence to guidelines
was higher in men compared with women. The occur-
rence of previous small peripheral hemorrhage did
not limit the use of antiplatelet therapy, on the con-
trary, in real life we found that is considered a limit
for prescription.
Our population was characterized by a low cardio-
vascular risk as indicated by the Framingham score
risk; however, we report a low adherence regarding
drugs prescription, mainly in women.
Discontinuation of secondary prevention with
aspirin has been associated with higher risk of cardio-
vascular events in some studies2,3 with indications of an
increased risk shortly after discontinuation. Aspirin is
often withdrawn because of surgery or bleeding, factors
that per se may stimulate platelet aggregation and
increase the risk of cardiovascular events.4,5,6
A high initial discontinuation rate was reported in a
previous study: 1 of 5 aspirin-naı¨ve patients did not
collect the second prescription of aspirin dispensed,
and the main persistence drop was during the first
year after aspirin initiation. In contrast, those who
picked up their second prescription had a modest dis-
continuation rate over time.7
We think that larger clinical trials evaluating the
effects of poor adherence to therapy and the risk of
cardiovascular events in women with minor hemor-
rhage should be conducted. It is well known that
there are significant disparities between women and
men in their intensity of medication use, and their like-
lihood of receiving guideline-based drug therapy.8
These differences indicate a need for more personalized
drug management to reduced clinical events.
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